J J Albers

2.0k total citations
28 papers, 1.7k citations indexed

About

J J Albers is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, J J Albers has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 15 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Cancer Research. Recurrent topics in J J Albers's work include Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Lipoproteins and Cardiovascular Health (14 papers) and Cancer, Lipids, and Metabolism (7 papers). J J Albers is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Lipoproteins and Cardiovascular Health (14 papers) and Cancer, Lipids, and Metabolism (7 papers). J J Albers collaborates with scholars based in United States and Canada. J J Albers's co-authors include S Marcovina, John D. Bagdade, Alan Chait, Hal Kennedy, Santica M. Marcovina, C H Chen, John D. Brunzell, GB McDonald, S M Grundy and Francesco Dati and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and American Journal of Clinical Nutrition.

In The Last Decade

J J Albers

28 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J J Albers United States 18 935 931 384 349 270 28 1.7k
Y Oschry Israel 17 879 0.9× 769 0.8× 337 0.9× 344 1.0× 293 1.1× 25 1.6k
J. Fröhlich Canada 25 863 0.9× 1.1k 1.2× 471 1.2× 362 1.0× 325 1.2× 79 2.0k
A.F.H. Stalenhoef Netherlands 21 777 0.8× 1.2k 1.3× 590 1.5× 380 1.1× 350 1.3× 44 2.2k
C.J. Packard United Kingdom 21 999 1.1× 925 1.0× 395 1.0× 370 1.1× 369 1.4× 58 2.2k
Melissa A. Austin United States 10 1.2k 1.3× 984 1.1× 432 1.1× 302 0.9× 191 0.7× 10 1.9k
R M Krauss United States 17 716 0.8× 611 0.7× 263 0.7× 231 0.7× 168 0.6× 24 1.2k
Helmut Schulte Germany 7 817 0.9× 795 0.9× 370 1.0× 248 0.7× 145 0.5× 7 1.4k
Kenneth G. Berge United States 14 974 1.0× 1.2k 1.3× 461 1.2× 303 0.9× 183 0.7× 27 1.9k
Gabriele Bittolo Bon Italy 20 870 0.9× 902 1.0× 451 1.2× 228 0.7× 304 1.1× 43 2.3k
W F Beltz United States 20 826 0.9× 742 0.8× 240 0.6× 222 0.6× 390 1.4× 28 1.7k

Countries citing papers authored by J J Albers

Since Specialization
Citations

This map shows the geographic impact of J J Albers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J J Albers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J J Albers more than expected).

Fields of papers citing papers by J J Albers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J J Albers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J J Albers. The network helps show where J J Albers may publish in the future.

Co-authorship network of co-authors of J J Albers

This figure shows the co-authorship network connecting the top 25 collaborators of J J Albers. A scholar is included among the top collaborators of J J Albers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J J Albers. J J Albers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chait, Alan, et al.. (1998). Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design.. PubMed. 14 Suppl A. 6A–13A. 13 indexed citations
2.
Albers, J J, Hal Kennedy, & Santica M. Marcovina. (1996). Evidence that Lp[a] contains one molecule of apo[a] and one molecule of apoB: evaluation of amino acid analysis data.. Journal of Lipid Research. 37(1). 192–196. 66 indexed citations
3.
Marzetta, C A, et al.. (1993). Lipid transfer protein-mediated distribution of HDL-derived cholesteryl esters among plasma apo B-containing lipoprotein subpopulations.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(6). 834–841. 16 indexed citations
4.
Marcovina, S, J J Albers, Francesco Dati, Thomas B. Ledue, & Robert F. Ritchie. (1991). International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. Clinical Chemistry. 37(10). 1676–1682. 212 indexed citations
5.
6.
Albers, J J & S Marcovina. (1989). Standardization of apolipoprotein B and A-I measurements.. Clinical Chemistry. 35(7). 1357–1361. 20 indexed citations
7.
Bagdade, John D., Papasani V. Subbaiah, & J J Albers. (1987). Effects of Serum from Oral Contraceptive Users on the Metabolism of Low Density Lipoprotein. The American Journal of the Medical Sciences. 294(4). 225–230. 2 indexed citations
8.
Cheung, Marian C., et al.. (1986). Abnormal composition of apoproteins C-I, C-II, and C-III in plasma and very-low-density lipoproteins of non-insulin-dependent diabetic Chinese.. Clinical Chemistry. 32(10). 1914–1920. 7 indexed citations
9.
Brinton, Eliot A., et al.. (1986). Binding of high density lipoprotein to cultured fibroblasts after chemical alteration of apoprotein amino acid residues.. Journal of Biological Chemistry. 261(1). 495–503. 111 indexed citations
10.
Albers, J J, et al.. (1985). Effects of interval and continuous running on HDL-cholesterol, apoproteins A-1 and B, and LCAT.. PubMed. 10(1). 52–9. 25 indexed citations
11.
Kenagy, Richard D., E L Bierman, Stephen M. Schwartz, & J J Albers. (1984). Metabolism of low density lipoprotein by bovine endothelial cells as a function of cell density.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 4(4). 365–371. 22 indexed citations
12.
Brunzell, John D., et al.. (1983). Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. Journal of Lipid Research. 24(2). 147–155. 260 indexed citations
13.
Lippel, K, H A Tyroler, Antonio M. Gotto, et al.. (1983). Workshop on apolipoprotein quantification.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 3(5). 452–464. 9 indexed citations
14.
15.
Tan, Meng H., et al.. (1980). Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.. PubMed. 3(3-4). 225–32. 10 indexed citations
16.
Subbaiah, Papasani V., J J Albers, C H Chen, & John D. Bagdade. (1980). Low density lipoprotein-activated lysolecithin acylation by human plasma lecithin-cholesterol acyltransferase. Identity of lysolecithin acyltransferase and lecithin-cholesterol acyltransferase.. Journal of Biological Chemistry. 255(19). 9275–9280. 94 indexed citations
17.
Lippel, K, et al.. (1978). External quality-control survey of cholesterol analyses performed by 12 lipid research clinics.. Clinical Chemistry. 24(9). 1477–1484. 20 indexed citations
18.
Chait, Alan, J J Albers, J. D. Brunzell, & W R Hazzard. (1977). TYPE-III HYPERLIPOPROTEINÆMIA ("REMNANT REMOVAL DISEASE"). The Lancet. 309(8023). 1176–1178. 66 indexed citations
19.
Bagdade, John D., Alberto Casaretto, & J J Albers. (1976). Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.. PubMed. 87(1). 38–48. 118 indexed citations
20.
Bachorik, Paul S., P D Wood, J J Albers, et al.. (1976). Plasma high-density lipoprotein cholesterol concentrations determined after removal of other lipoproteins by heparin/manganese precipitation or by ultracentrifugation.. Clinical Chemistry. 22(11). 1828–1834. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y Oschry Breakdown of academic impact, for papers by J. Fröhlich Breakdown of academic impact, for papers by A.F.H. Stalenhoef Breakdown of academic impact, for papers by C.J. Packard Breakdown of academic impact, for papers by Melissa A. Austin Breakdown of academic impact, for papers by R M Krauss Breakdown of academic impact, for papers by Helmut Schulte Breakdown of academic impact, for papers by Kenneth G. Berge Breakdown of academic impact, for papers by Gabriele Bittolo Bon Breakdown of academic impact, for papers by W F Beltz
Rankless by CCL
2026